Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 10, 2001

View Archived Issues

MorphoSys Enters EUR22M Deal With Centocor Around HuCAL

SHIP2 Gene Makes Waves As Potential Type II Diabetes Target

European Parliament Report Calls For Separation Of Biotech Areas

Xantos Formed Around Platform To Perform Functional Genomics

GenOdyssee Applies For Patents Covering Genetic Variants Method

Other News To Note

MediGene's Genital Warts Drug Enters Phase III Clinical Trials

Combio Spun Off From Carlsberg To Develop Chemistry Platform

Oxford BioMedica Moving To LSE Following TroVax Trial Approval

Eurofins Beefing Up Detection Business Through Acquisitions

Phytopharm Sees Encouraging Results In Phase I P54 Study

PhotoCure Reports Skin Cancer Cures In Phase III PDT Trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...